TMCNet:  Research and Markets: U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation (Executive Summary)

[February 15, 2013]

Research and Markets: U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation (Executive Summary)

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/8pcpr4/u_s_market_for) has announced the addition of the "U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation (Executive Summary)" report to their offering.

In 2012, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices market was valued at nearly $6.8 billion.

The CRM, electrophysiology and ablation device market includes pacemakers, cardia resynchronization therapy (CRT) devices, implantable cardioverter defibrillators (ICDs), cardiac stimulation leads, external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices. Over the forecast period, the CRM, electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced CRM devices. However, the aftermath of the economic recession of 2008 and the sluggish U.S. economy that followed have continued to stifle growth in the markets.


Scope: This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

- Competitor Analysis

- Identified Strategic Opportunities

- Market Overview by Segment

- Trend Analysis by Segment

- Market Drivers & Limiters

- Mergers & Acquisitions

- Customer Feedback and Market Monitoring

For more information visit http://www.researchandmarkets.com/research/8pcpr4/u_s_market_for


[ Back To Customer's Homepage ]